HIGHLIGHTS
- who: Bita Amir Taghavi et al. from the Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran have published the research work: Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy, in the Journal: Molecules 2022, 3545 of /2022/
- how: In this study head and neck carcinoma cell lines were used to investigate the role of PD-L1 along with DNA repair complex (Mer11 Rad50 NBS1 MRN) in cisplatin-induced chemoresistance. That data showed that apoptosis was increased significantly in CA46 sh . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.